Pulmonx (LUNG) Change in Receivables (2019 - 2025)

Pulmonx (LUNG) has reported Change in Receivables for 7 consecutive years, with -$1.4 million the latest figure, recorded in Q3 2025.

• On a quarterly basis, Change in Receivables fell 492.76% year-over-year to -$1.4 million in Q3 2025; TTM through Sep 2025 was $2.3 million, a 70.96% increase from a year earlier, with the FY2024 full-year figure at $1.3 million, down 57.86% from the prior year.
• Change in Receivables was -$1.4 million for Q3 2025 at Pulmonx, down from $1.2 million in the prior quarter.
• Over five years, Change in Receivables peaked at $1.8 million in Q4 2023 and troughed at -$1.4 million in Q3 2025.
• A 5-year average of $503421.1 and a median of $715000.0 in 2023 frame the typical range for Change in Receivables.
• Across the five-year window, Change in Receivables soared 793.41% in 2023 and tumbled 492.76% in 2025, its largest moves.
• Over 5 years, Change in Receivables stood at -$387000.0 in 2021, then soared by 431.78% to $1.3 million in 2022, then jumped by 37.23% to $1.8 million in 2023, then dropped by 1.19% to $1.7 million in 2024, then tumbled by 180.99% to -$1.4 million in 2025.
• The last three Change in Receivables figures came in at -$1.4 million (Q3 2025), $1.2 million (Q2 2025), and $721000.0 (Q1 2025), per Business Quant data.